Opus Genetics, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Total Assets↑+36.3% +$13M
$50M
Current Assets↑+36.7% +$13M
$50M
Cash & Equivalents↑+48.7% +$15M
$45M
ST Investments↓-100.0% -$2K
$0
Receivables↓-44.0% -$2M
$2M
Net PPE↓-21.0% -$53K
$199K
Total Liabilities↑+208.9% +$24M
$35M
Current Liabilities↓-31.1% -$4M
$8M
Account Payables↑+4.6% +$145K
$3M
Long-Term Debt
$1M
Short-Term Debt
—
Stockholders Equity↑+128.3% +$9M
$15M
Retained Earnings↓-35.7% -$50M
$-189M
Operating Lease ROU Asset
—
Operating Lease Liability
—
Gross PP&E
$25K
Accumulated Depreciation
$25K
Contract Liability
—
Contract Liability (Current)
—